Biotalys (Euronext – BTLS), provided a company update following a strategic review of the company by CEO Kevin Helash and the board of directors. The review leads to a shift to the second-generation AGROBODY™ technology to develop protein-based biocontrols for crop and food protection. This move to AGROBODY 2.0 entails organizational changes to concentrate resources on core R&D capabilities while focusing on obtaining registration for Biotalys’ first product candidate EVOCA.
Read Full News Here :- https://www.biotalys.com/media/news/biotalys-provides-company-update